KLI
CVRS

Kelman-Lazarov Inc’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Kelman-Lazarov Inc’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-66,950
Closed -$92K – 111
2018
Q1 		$92K Buy
66,950
+273
+0.4% +$317 0.05% 109
2017
Q4 		$67K Buy
66,677
+10,000
+18% +$11.3K 0.03% 119
2017
Q3 		$86K Buy
56,677
+20,500
+57% +$34.3K 0.05% 116
2017
Q2 		$67K Buy
+36,177
New +$48.2K 0.04% 119
2017
Q1 		– Sell
-19,177
Closed -$13.4K – 281
2016
Q4 		$13.4K Buy
19,177
+6,877
+56% +$5.79K 0.01% 239
2016
Q3 		$13.4K Buy
+12,300
New +$16.4K 0.01% 273

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PVAM
Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Kelman-Lazarov Inc's CVRS Position: Q2 2018 in Review

Kelman-Lazarov Inc sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2018, closing a stake of 66,950 shares — an estimated $92K sold.

Kelman-Lazarov Inc first reported a position in CVRS in Q3 2016 and held it in 6 quarters. The position peaked at $92K in Q1 2018. 53 funds tracked by Wall St. Rank hold CVRS as of Q2 2018.

  • Kelman-Lazarov Inc reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q2 2018 after selling out during the quarter.
  • Kelman-Lazarov Inc sold 66,950 CORINDUS VASCULAR ROBOTICS, INC shares in Q2 2018, an estimated $92K.
  • Kelman-Lazarov Inc first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q3 2016 and held it in 6 quarters.
  • Kelman-Lazarov Inc's CORINDUS VASCULAR ROBOTICS, INC position peaked at $92K in Q1 2018.
  • 53 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2018.

Based on Kelman-Lazarov Inc's 13F filing for Q2 2018, filed 3 Aug 2018.